These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 16428781

  • 1. Analysis of antibodies directed against merozoite surface protein 1 of the human malaria parasite Plasmodium falciparum.
    Woehlbier U, Epp C, Kauth CW, Lutz R, Long CA, Coulibaly B, Kouyaté B, Arevalo-Herrera M, Herrera S, Bujard H.
    Infect Immun; 2006 Feb; 74(2):1313-22. PubMed ID: 16428781
    [Abstract] [Full Text] [Related]

  • 2. Passive transfer of growth-inhibitory antibodies raised against yeast-expressed recombinant Plasmodium falciparum merozoite surface protein-1(19).
    Gozalo A, Lucas C, Cachay M, Wellde BT, Hall T, Bell B, Wood J, Watts D, Wooster M, Lyon JA, Moch JK, Haynes JD, Williams JS, Holland C, Watson E, Kester KE, Kaslow DC, Ballou WR.
    Am J Trop Med Hyg; 1998 Dec; 59(6):991-7. PubMed ID: 9886211
    [Abstract] [Full Text] [Related]

  • 3. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
    Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.
    Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
    [Abstract] [Full Text] [Related]

  • 4. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
    Jäschke A, Coulibaly B, Remarque EJ, Bujard H, Epp C.
    Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
    [Abstract] [Full Text] [Related]

  • 5. Antibodies against multiple merozoite surface antigens of the human malaria parasite Plasmodium falciparum inhibit parasite maturation and red blood cell invasion.
    Woehlbier U, Epp C, Hackett F, Blackman MJ, Bujard H.
    Malar J; 2010 Mar 18; 9():77. PubMed ID: 20298576
    [Abstract] [Full Text] [Related]

  • 6. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV, Biswas S, Pillai CR, Saxena RK.
    Vaccine; 2008 Aug 18; 26(35):4526-35. PubMed ID: 18590786
    [Abstract] [Full Text] [Related]

  • 7. Identification of a novel antigenic domain of Plasmodium falciparum merozoite surface protein-1 that specifically binds to human erythrocytes and inhibits parasite invasion, in vitro.
    Nikodem D, Davidson E.
    Mol Biochem Parasitol; 2000 Apr 30; 108(1):79-91. PubMed ID: 10802320
    [Abstract] [Full Text] [Related]

  • 8. Regulation of antibody specificity to Plasmodium falciparum merozoite surface protein-1 by adjuvant and MHC haplotype.
    Chang SP, Nikaido CM, Hashimoto AC, Hashiro CQ, Yokota BT, Hui GS.
    J Immunol; 1994 Apr 01; 152(7):3483-90. PubMed ID: 8144929
    [Abstract] [Full Text] [Related]

  • 9. Amino acid dimorphism and parasite immune evasion: cellular immune responses to a promiscuous epitope of Plasmodium falciparum merozoite surface protein 1 displaying dimorphic amino acid polymorphism are highly constrained.
    Daubenberger CA, Nickel B, Ciatto C, Grütter MG, Pöltl-Frank F, Rossi L, Siegler U, Robinson J, Kashala O, Patarroyo ME, Pluschke G.
    Eur J Immunol; 2002 Dec 01; 32(12):3667-77. PubMed ID: 12516559
    [Abstract] [Full Text] [Related]

  • 10. Vaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.
    Egan AF, Blackman MJ, Kaslow DC.
    Infect Immun; 2000 Mar 01; 68(3):1418-27. PubMed ID: 10678955
    [Abstract] [Full Text] [Related]

  • 11. A recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.
    Chang SP, Case SE, Gosnell WL, Hashimoto A, Kramer KJ, Tam LQ, Hashiro CQ, Nikaido CM, Gibson HL, Lee-Ng CT, Barr PJ, Yokota BT, Hut GS.
    Infect Immun; 1996 Jan 01; 64(1):253-61. PubMed ID: 8557348
    [Abstract] [Full Text] [Related]

  • 12. Antibody responses to a novel Plasmodium falciparum merozoite surface protein vaccine correlate with protection against experimental malaria infection in Aotus monkeys.
    Cavanagh DR, Kocken CH, White JH, Cowan GJ, Samuel K, Dubbeld MA, Voorberg-van der Wel A, Thomas AW, McBride JS, Arnot DE.
    PLoS One; 2014 Jan 01; 9(1):e83704. PubMed ID: 24421900
    [Abstract] [Full Text] [Related]

  • 13. Immunogenicity and in vitro protective efficacy of recombinant Mycobacterium bovis bacille Calmette Guerin (rBCG) expressing the 19 kDa merozoite surface protein-1 (MSP-1(19)) antigen of Plasmodium falciparum.
    Nurul AA, Norazmi MN.
    Parasitol Res; 2011 Apr 01; 108(4):887-97. PubMed ID: 21057812
    [Abstract] [Full Text] [Related]

  • 14. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH, Arisue N, Ito D, Hasegawa T, Palacpac NMQ, Egwang TG, Horii T, Takashima E, Tsuboi T.
    Vaccine; 2016 Nov 04; 34(46):5612-5622. PubMed ID: 27692771
    [Abstract] [Full Text] [Related]

  • 15. Functional conservation of the malaria vaccine antigen MSP-119across distantly related Plasmodium species.
    O'Donnell RA, Saul A, Cowman AF, Crabb BS.
    Nat Med; 2000 Jan 04; 6(1):91-5. PubMed ID: 10613831
    [Abstract] [Full Text] [Related]

  • 16. Biochemical and immunological characterization of E. coli expressed 42 kDa fragment of Plasmodium vivax and P. cynomolgi bastianelli merozoite surface protein-1.
    Kaushal DC, Kaushal NA, Narula A, Kumar N, Puri SK, Dutta S, Lanar DE.
    Indian J Biochem Biophys; 2007 Dec 04; 44(6):429-36. PubMed ID: 18320841
    [Abstract] [Full Text] [Related]

  • 17. Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.
    Guevara Patiño JA, Holder AA, McBride JS, Blackman MJ.
    J Exp Med; 1997 Nov 17; 186(10):1689-99. PubMed ID: 9362529
    [Abstract] [Full Text] [Related]

  • 18. Immune responses elicited by co-immunization of Plasmodium vivax and P. falciparum MSP-1 using prime-boost immunization strategies.
    Mehrizi AA, Zakeri S, Rafati S, Salmanian AH, Djadid ND.
    Parasite Immunol; 2011 Nov 17; 33(11):594-608. PubMed ID: 21883290
    [Abstract] [Full Text] [Related]

  • 19. Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparum.
    Cheng XJ, Hayasaka H, Watanabe K, Tao YL, Liu JY, Tsukamoto H, Horii T, Tanabe K, Tachibana H.
    Infect Immun; 2007 Jul 17; 75(7):3614-20. PubMed ID: 17452466
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.